Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

TLSA

+ Watchlist+ Portfolio

Tiziana Life Sciences Ltd

Regulated industryPhysical productsSells to businessesDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$0.65
52-Week Range
$0.55 – $1.90
Market Cap
$103.50M
P/E (TTM)
—
EPS (TTM)
-0.21
Dividend Yield
0.00%
Advanced Metrics
Price/Book
—
PEG Ratio
—
Return on Equity
-780.60%
Return on Assets
-103.16%
Gross Margin
0.00%
Operating Margin
0.00%
Profit Margin
0.00%
Current Ratio
0.69
Debt/Equity
—
Total Debt
$932.00K
Free Cash Flow
$-6.38M
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$101.25M

Market Snapshot

About

Tiziana Life Sciences Ltd is a biotechnology company focused on discovering and developing transformative therapies for cancer and immune-modulated inflammatory diseases. The company is advancing novel intranasal immunotherapies and other innovative treatments.